Minerva Surgical, Inc.
Minerva Surgical, Inc.（UTRS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · UTRS · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Minerva Surgical, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
UTRS 季度内部人买卖趋势
UTRS 内幕交易卖出 · UTRS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
近期内幕交易记录
UTRS 高管卖出股份 · UTRS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 9, 2023 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Purchase | 24,437,927 | $5.00M⚡ | Form 4 |
| May 2, 2022 | Skalnyi Evgueni V. VP Medical Affairs | Award | 49,755 | — | Form 4 |
| May 2, 2022 | Filloux Dominique J. COO | Award | 60,198 | — | Form 4 |
| May 2, 2022 | Jung Joel R CFO | Award | 60,198 | — | Form 4 |
| May 2, 2022 | Clapper David M President and CEO | Award | 229,732 | — | Form 4 |
| Jul 19, 2022 | Sung Derrick Director | Award | 86,956 | $200K | Form 4 |
| Jun 10, 2022 | Behbahani Ali Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | JAFFE ROSS A MD Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Renzi David Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Hunt Niquette L. Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Coste Catherine Director | Award | 49,792 | $120K | Form 4 |
| Jun 10, 2022 | Anderson Jill Director | Award | 49,792 | $120K | Form 4 |
| Dec 15, 2021 | Skalnyi Evgueni V. VP Medical Affairs | Award | 20,250 | — | Form 4 |
| Dec 15, 2021 | Jung Joel R CFO | Award | 24,500 | — | Form 4 |
| Dec 15, 2021 | Filloux Dominique J. COO | Award | 24,500 | — | Form 4 |
| Dec 15, 2021 | Clapper David M President and CEO | Award | 93,500 | — | Form 4 |
| Dec 15, 2021 | Clapper David M President and CEO · Director | Award | 93,500 | — | Form 4 |
| Dec 13, 2021 | Clapper David M President and CEO · Director | Purchase | 25,000 | $123K | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 3,306 | — | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 4,196 | — | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 704 | — | Form 4 |
| Oct 26, 2021 | Behbahani Ali Director | Other | 281 | — | Form 4 |
| Oct 26, 2021 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Purchase | 1,300,000 | $15.60M⚡ | Form 4 |
| Oct 26, 2021 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Other | 3,503,021 | — | Form 4 |
| Oct 26, 2021 | NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner | Other | 3,409,709 | — | Form 4 |
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
日期
Feb 9
股数
24,437,927
均价
$0.20
总金额
$5.00M ⚡
Clapper David M
President and CEO · Director
日期
Dec 13
股数
25,000
均价
$4.94
总金额
$123K
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
日期
Oct 26
股数
1,300,000
均价
$12.00
总金额
$15.60M ⚡
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
日期
Oct 26
股数
3,503,021
均价
—
总金额
—
NEW ENTERPRISE ASSOCIATES 13 LP
10 percent owner
日期
Oct 26
股数
3,409,709
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 UTRS 内幕交易
UTRS 内幕交易
Minerva Surgical, Inc.（UTRS）内幕交易数据来源于公司内部人（包括UTRS）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。UTRS内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Minerva Surgical, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
UTRS 内幕交易 · 5个问题Minerva Surgical, Inc.（UTRS）的内部人包括高管和董事，如UTRS等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026